Hannover Medical School

This study aims to find biological markers in the blood or liver that can tell doctors when it might be safe for patients with chronic hepatitis D to stop taking the drug bulevirtide. Researchers will stop treatment in 20 patients whose virus is well-controlled and monitor them f…

This study is testing whether a diabetes drug called empagliflozin is safe and can help slow the progression of a genetic kidney disease called ADPKD. It involves 44 adults with rapidly progressing disease, some of whom are already taking the standard medication. Researchers will…

This study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure ch…

This study is testing how to best set up a national lung cancer screening program in Germany. It will enroll over 12,000 current and former smokers aged 55-79 to compare different methods of identifying high-risk people and using CT scans to find cancer early. The goal is to crea…

This study aims to find the best way to help adults with Long COVID manage their debilitating fatigue. Researchers are comparing three online programs: a psychosomatic (mind-body) talk therapy, a physical activity program, and a combination of both. The goal is to see which appro…

This study aims to use artificial intelligence (AI) to predict how well patients with autoimmune hepatitis will respond to standard treatments. Researchers will analyze data from thousands of patients to build and test computer models that can forecast treatment success at 6 and …